Quantification of myocardial oxygen consumption with 17O-CMR: initial study
2011

Measuring Heart Oxygen Use with 17O-CMR

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): Zheng Jie, Muccigrosso David, Abendschein Dana

Primary Institution: Washington University In St. Louis, Saint Louis, MO, USA

Hypothesis

This study aims to develop a new non-invasive CMR method using 17O based blood tracer to assess myocardial oxygenation and MVO2.

Conclusion

The 17O-CMR may provide a direct and non-invasive measurement of oxygen consumption for better evaluations of patients with various heart conditions.

Supporting Evidence

  • The averaged MVO2 in normal dogs was 3.96 ± 0.97 μmol/g/min, consistent with PET measurements.
  • For the 70% stenotic dog, MVO2 was 2.84 μmol/g/min in the normal segment and 1.57 μmol/g/min in the lateral region.
  • The study showed that the oxygen deficit area was smaller than the hypo-perfusion size.

Takeaway

This study is like finding a new way to see how much oxygen the heart is using without needing to do anything invasive.

Methodology

The study involved injecting a 17O blood tracer into normal and ischemic dogs and using CMR imaging to measure myocardial oxygen consumption.

Participant Demographics

Normal mongrel dogs and myocardial ischemic dogs.

Digital Object Identifier (DOI)

10.1186/1532-429X-13-S1-P345

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication